Elizaveta Melnikova

Mrs. Elizaveta Melnikova


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 October 2020 in Terapevticheskii arkhiv
Verified
Journal Article
Open access
PDF file
EMElizaveta Melnikova
Elizaveta Melnikova
Oksana RymarOksana Rymar
Oksana Rymar
AIA. A. Ivanova
A. A. Ivanova
SMSvetlana Vladimirovna Mustafina
Svetlana Vladimirovna Mustafina
MSMarina Shapkina
Marina Shapkina
МСМельникова Елизавета Сергеевна
Мельникова Елизавета Сергеевна
Aim.To study the possibility of using polymorphisms of genesTCF7L2,FABP2,KCNQ1,ADIPOQas markers for predicting the development of type 2 diabetes mellitus (T2D) in the population of Novosibirsk. Materials and methods.On the basis of prospective observation of a representative population sample of residents of Novosibirsk (HAPIEE), 2 groups were formed according to the case-control principle (case people who had diabetes mellitus 2 over 10 years of observation, and control people who did not developed disorders of carbohydrate metabolism). T2D group (n=443, mean age 56.26.7 years, men 29.6%, women 70.4%), control group (n=532, mean age 56.17.1 years, men 32.7%, women 67.3%). DNA was isolated by phenol-chloroform extraction. Genotyping was performed by the method of polymerase chain reaction with subsequent analysis of restriction fragment length polymorphism, polymerase chain reaction in real time. Statistical processing was carried out using the SPSS 16.0 software package. Results and discussion.No significant effect of rs1799883 of theFABP2gene, rs2237892 of theKCNQ1gene, and rs6773957 of theADIPOQgene on the risk of developing T2D was found. Genotypes TT and TC rs7903146 of theTCF7L2gene are genotypes for the risk of developing T2D (relative risk RR 3.90, 95% confidence interval CI 2.316.61,p0.001; RR 1.86, 95% CI 1.422.43,p0.001, respectively). The CC genotype rs7903146 of theTCF7L2gene is associated with a protective effect against T2D (RR 0.37, 95% CI 0.290.49,p0.001). When theTCF7L2gene is included in the model for assessing the risk of developing T2D rs7903146, it retains its significance in both men and women. Conclusion.The rs7903146 polymorphism of theTCF7L2gene confirmed its association with the prognosis of the development of T2D, which indicates the possibility of considering it as a candidate for inclusion in a diabetes risk meter. Variants of risk meters have been developed to assess the prognosis of the development of diabetes mellitus 2 in men and women aged 4569 years during 10 years of follow-up. The association with the prognosis of the development of T2D polymorphisms rs1799883 of theFABP2gene, rs2237892 of theKCNQ1gene and rs6773957 of theADIPOQgene was not found.

8 July 2023 in Bulletin of Siberian Medicine
Verified
Journal Article
Open access
PDF file
AIA. A. Ivanova
A. A. Ivanova
AGA. A. Gurazheva
A. A. Gurazheva
EMElizaveta Melnikova
Elizaveta Melnikova
Vladimir Nikolaevich MaksimovVladimir Nikolaevich Maksimov
Vladimir Nikolaevich Maksimov
ENE. G. Nemcova
E. G. Nemcova
Aim. To study new molecular genetic markers of Gilbert’s syndrome (GS).Materials and methods. It was a case – control study. The GS group included 125 people (mean age 38.5 ± 11.9 years, 58.9% were men) with unconjugated hyperbilirubinemia; known causes of unconjugated hyperbilirubinemia were excluded. The control group (n = 323, mean age 48.9 ± 11.9 years, 53.2% were men) was a random sample of individuals from the DNA bank of participants of the HAPIEE and MONICA projects. DNA was isolated by phenol – chloroform extraction from venous blood. Genotyping of groups by rs3064744, rs34993780, rs56059937, rs4148323, and rs4124874 single nucleotide polymorphisms (SNPs) in the UGT1A1 gene was performed by polymerase chain reaction followed by the polyacrylamide gel analysis according to the author’s protocols.Results. For rs34993780 and rs56059937, no carriers of a rare allele were found in the GS group and the control group. In the GS group, two carriers of a heterozygous mutation rs4148323 were found. Statistically significant differences between the groups were found in the frequencies of rs4124874: homozygous GG was statistically significantly more common in the GS group than in the control group (odds ratio (OR) = 11.8, 95% confidence interval (CI) 6.9–20.3, p < 0.001).Conclusion. The GG genotype of rs4124874 in the UGT1A1 gene is associated with an increased risk of GS. Carriers of the rare heterozygous mutation rs4148323 were found in the GS group.

5 June 2022 in Diabetes mellitus
Verified
Journal Article
Open access
PDF file
EMElizaveta Melnikova
Elizaveta Melnikova
SMSvetlana Vladimirovna Mustafina
Svetlana Vladimirovna Mustafina
Oksana RymarOksana Rymar
Oksana Rymar
AIA. A. Ivanova
A. A. Ivanova
LSL. V. Shcherbakova
L. V. Shcherbakova
VMV. N. Maksimov
V. N. Maksimov
BACKGROUND: The prevalence of Type 2 diabetes mellitus (T2DM) has reached epidemic proportions and it is estimated to affect over 400 million people worldwide. Moreover, the incidence of diabetes is expected to continue to rise and it is projected to affect nearly one of the three individuals by the year 2050. These alarming projections suggest that there is an urgent need for the development and implementation of novel prevention and treatment strategies to combat the rise in T2DM.AIM: To study the possibility of using polymorphisms of genes SLC30A8 and MC4R as markers for predicting the development of T2D in the population of Novosibirsk.MATERIALS AND METHODS: On the basis of prospective follow-up of a representative population sample of residents of Novosibirsk (The HAPIEE Project), 2 groups were formed according to the “case-control” principle (case — people who had diabetes mellitus 2 over 10 years of follow-up, and control — people who did not developed disorders of carbohydrate metabolism). T2D group (n = 443, mean age 56.2 ± 6.7 years, men — 29.6%, women — 70.4%), control group (n = 532, mean age 56.1 ± 7.1 years, men — 32.7%, women — 67.3%). DNA was isolated by phenol-chloroform extraction. Genotyping was performed by the method of polymerase chain reaction with subsequent analysis of restriction fragment length polymorphism, polymerase chain reaction in real time. Statistical processing was carried out using the SPSS 16.0 software package.RESULTS: Genotype TT rs13266634 of the SLC30A8 gene was associated with the risk of developing T2D (relative risk — RR 1.51, 95% confidence interval — CI 1.11–2.05, p =0.008). The CC genotype rs13266634 of the SLC30A8 gene was associated with a protective effect against T2D (RR 0.57, 95% CI 0.35–0.92, p=0.026). No significant effect of rs17782313 of the MC4R gene on the risk of developing T2D was found.CONCLUSION: The rs13266634 polymorphism of the SLC30A8 gene confirmed its association with the prognosis of the development of T2D, which indicates the possibility of considering it as a candidate for inclusion in a diabetes risk score. The association between polymorphisms rs17782313 of the MC4R gene and the prognosis of the development of T2D was not found.

18 September 2025 in Doctor.Ru
Verified
Journal Article
Open access
Vladimir Nikolaevich MaksimovVladimir Nikolaevich Maksimov
Vladimir Nikolaevich Maksimov
RNRussian Federation Novosibirsk
Russian Federation Novosibirsk
SMS.V. Michin
S.V. Michin
YIYu.V. Ivanova
Yu.V. Ivanova
EMElizaveta Melnikova
Elizaveta Melnikova
SMSofia Malyutina
Sofia Malyutina
Aim. To study the association of rs9939609 of the FTO gene with various obesity phenotypes, its individual parameters, and some risk factors in a sample of women Design. Cross-sectional cohort study. Materials and methods. The study was conducted on the basis of the population sample of the HAPIEE project, the age of the participants was — 45–69 years (n = 1036). Groups of women were formed, selected by body mass index (BMI) using the criteria of the World Health Organization. DNA was isolated from blood using the phenol-chloroform extraction method. Genotyping of the rs9939609 gene FTO was performed using polymerase chain reaction (PCR) with restriction fragment length polymorphism and real-time PCR (TaqMan probes). The frequency of genotypes in groups with different BMI, with different body roundness indexes (BRI), waist and hip circumference; with morbid obesity (MO) and abdominal obesity (AO) was analyzed. Results. When comparing the frequencies of the A allele (AA and AT genotypes) and the TT genotype in groups with different BMIs, significant differences were obtained (p = 0.007). The highest frequency of the TT genotype (38.5%) was in the group of women with a BMI of 18.5 to 24.9 kg/m2, the lowest (23.5%) — with a BMI of 35 to 39.9 kg/m2. In this group, the AA genotype was most common. The frequency of carriage of the AT genotype increased nonlinearly with increasing BMI. The statistical significance of differences in BMI between carriers of different genotypes according to the Kruskal — Wallis — test is less than 0.001. Significant differences were also observed in waist (p = 0.001) and hip (p < 0.001) circumferences — the smallest in carriers of the TT genotype. In univariate logistic regression analysis with age-adjusted adjustment, the odds ratio (OR) of having MO in the AA genotype — 1.80 (95% confidence interval (CI): 1.09–2.95; p = 0.021), in the AT genotype — 1.82 (95% CI: 1.23–2.68; p = 0.002), and in the TT genotype — 0.56 (95% CI: 0.39–0.81; p = 0.002). In the univariate logistic regression analysis with age-adjusted analysis, the significance of the TT genotype carriage as a conditionally protective factor in relation to the development of MO (OR = 0.56; 95% CI: 0.34–0.91; p = 0.021) and AO (OR = 0.65; 95% CI: 0.45–0.94; p = 0.023) was preserved, as was the increased probability of AO in carriers of the AT genotype (OR = 1.53; 95% CI: 1.15–2.02; p = 0.003) and AA genotype (OR = 1.54; 95% CI: 1.06–2.23; p = 0.023). Conclusion. Carriage of the A allele of rs9939609 of the FTO gene is an important factor associated with various obesity phenotypes in women. Due to the diversity of factors associated with obesity, it is necessary to continue research in this area to develop effective personalized preventive and therapeutic strategies. Keywords: nucleotide sequence variant, obesity, morbid, abdominal, body roundness index, FTO gene, rs9939609, body mass index

17 June 2024 in Obesity and metabolism
Verified
Journal Article
Open access
PDF file
AIA. A. Ivanova
A. A. Ivanova
EMElizaveta Melnikova
Elizaveta Melnikova
VZValentina Zorina
Valentina Zorina
AGA. A. Gurazheva
A. A. Gurazheva
SMS. V. Maksimova
S. V. Maksimova
Vladimir Nikolaevich MaksimovVladimir Nikolaevich Maksimov
Vladimir Nikolaevich Maksimov
BACKGROUND: Obesity is a widespread disease associated with serious complications. Obesity is a risk factor for many chronic diseases. The most common type of obesity is polygenic obesity, the pathogenesis of which involves external and internal factors, including genetic ones.AIM: Search and study of the association of variants of the nucleotide sequence rs9939609 of the FTO gene, rs7903146 of the TCF7L2 gene, rs1799883 of the FABP2 gene, rs1800497 of the DRD2 gene, rs17782313 of the MC4R gene with morbid obesity in women.MATERIALS AND METHODS: Study design is case-control study. The morbid obesity group and the control group were formed from the DNA bank of participants of the international project HAPIEE. Genotyping was performed by PCR-RFLP and real-time PCR (TaqMan probes, Applied Biosystems, USA). Statistical analysis was performed in SPSS software using Pearson’s chi-square test, Fisher’s exact two-tailed test with Yates’ correction for continuity. The significance level was used p0.05). In the group of morbid obesity, the proportion of carriers of the TT genotype rs9939609 of the FTO gene was statistically significantly lower, and the AT genotype was significantly higher than in the control group (OR=0.579, 95% CI 0.399-0.840, p=0.004; OR=1.408, 95% CI 1.003- 1.976, p=0.047, respectively). The heterozygous TC genotype rs17782313 of the MC4R gene is statistically significantly more common (OR=1.825, 95% CI 1.257-2.652, p=0.002), while the homozygous TT genotype is less common (OR=0.500, 95% CI 0.346-0.723, p<0.001) in group of morbid obesity compared with the control group.CONCLUSION: Heterozygous genotypes of the rs9939609 of the FTO gene (AT) and rs17782313 of the MC4R gene (TC) are risk genotypes; the homozygous genotype TT of the variants is protective for morbid obesity in women. Single nucleotide variants rs7903146 of the TCF7L2 gene, rs1799883 of the FABP2 gene, and rs1800497 of the DRD2 gene are not associated with morbid obesity in women.

1 January 2025 in Doctor.Ru
Verified
Journal Article
Closed access
EMElizaveta Melnikova
Elizaveta Melnikova
RNRussian Federation Novosibirsk
Russian Federation Novosibirsk
Oksana RymarOksana Rymar
Oksana Rymar
SMSvetlana Vladimirovna Mustafina
Svetlana Vladimirovna Mustafina
Vladimir Nikolaevich MaksimovVladimir Nikolaevich Maksimov
Vladimir Nikolaevich Maksimov
Aim. According to the literature study the effectiveness and accuracy of models for predicting the risk of developing type 2 diabetes mellitus T2DM, including genetic markers. Key points. The article presents the results of foreign studies on the development of models for predicting the risk of developing T2DM using various clinical characteristics, biochemical indicators and genetic markers. Thematic sources from the PubMed database were analyzed. According to the literature genetic markers are useful risk factors for developing T2DM, which are not affected by reverse causality. Early studies based on a small number of nucleotide variants found small additional predictive value for genetic markers compared with clinical risk factors. Recent studies based on a larger number of variants have shown significant predictive value. Conclusion. Overall, additional research is need to better understanding the genetic mechanisms and potential causal links between nucleotide variants and the risk of developing of T2DM. This research could provide more insight into personalized therapy options for patients with a higher risk of developing T2DM. Keywords: type 2 diabetes mellitus, genetic markers, predicting the risk